We are live on ! Find out more
MESO

Mesoblast

42 hedge funds and large institutions have $16.2M invested in Mesoblast in 2021 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 8 increasing their positions, 12 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

92% more call options, than puts

Call options by funds: $3.79M | Put options by funds: $1.97M

13% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 8

2% more funds holding

Funds holding: 4142 (+1)

0.02% less ownership

Funds ownership: 0.27%0.26% (-0.02%)

24% less capital invested

Capital invested by funds: $21.2M → $16.2M (-$5.01M)

33% less repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 12

Holders
42
Holders Change
+1
Holders Change %
+2.44%
% of All Funds
0.64%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
9
Increased
8
Reduced
12
Closed
8
Calls
$3.79M
Puts
$1.97M
Net Calls
+$1.82M
Net Calls Change
+$1.51M

MESO Hedge Fund Activity: Q4 2021 in Review

42 of the 6,518 institutional investors tracked by Wall St. Rank reported a position in Mesoblast (MESO) for Q4 2021, worth a combined $16.2M — down 24% from $21.2M a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new MESO positions and 8 closed out — a net gain of 1 holder — while 8 added to existing stakes and 12 trimmed.

The largest buyer was Virtu Financial, opening a new position worth an estimated $260K. The largest seller was Jacob Asset Management of New York, exiting entirely with an estimated $1.04M sold.

  • 42 institutional investors held Mesoblast (MESO) as of Q4 2021, up from 41 in Q3 2021.
  • Funds reported $16.2M of Mesoblast stock for Q4 2021, down 24% quarter-over-quarter.
  • 9 funds opened new Mesoblast positions in Q4 2021 and 8 closed out, a net change of +1 holder.
  • The largest Mesoblast buyer in Q4 2021 was Virtu Financial, an estimated $260K added.
  • The largest Mesoblast seller in Q4 2021 was Jacob Asset Management of New York, an estimated $1.04M sold.

Based on aggregated 13F filings for Q4 2021.